Text Size
- News Releases
- What's New
- 22 Jun
- Galderma Announces Topline Results of OLYMPIA 2 Study Evaluating Nemolizumab in Prurigo Nodularis
- 20 Jun
- Anti-CD20 Monoclonal Antibody Rituxan Approved for the Prevention of Recurrence of Neuromyelitis Optica Spectrum Disorder
- 20 Jun
- Chugai Obtains Regulatory Approval for Hemlibra for Additional Indication of Acquired Hemophilia A
- 20 Jun
- Chugai Obtains Partial Change Approval for Neutrogin and Avastin Based on Public Knowledge-based Applications
- 09 Jun
- Notice of Filing an Appeal in Patent Infringement Lawsuit concerning Edirol Capsule
- Share this site
